Spring direct naar de hoofdnavigatie of de inhoud

Life Sciences sector

biotechnology

Life Sciences

Life Sciences

In life sciences, including biotechnology, V.O. represents clients in a broad range of traditional pharmaceutical as well as biological technologies, including immunology, virology, molecular biology, animal and plant genetics, gene therapy, protein chemistry, pharmacology, enzymology, bioinformatics and others. Specific areas of expertise include among others diagnostics, recombinant cytokines, antibody technology, personalized medicine, biomarkers, recombinant antigens and vaccines, and antisense and small RNA technology.

From start-ups to multinationals

Our client base in the life sciences and biotechnology sector ranges from biotech start-ups to multinationals. Working for and with biotech start-ups requires a special approach, as balancing research and commercial development may be complex. The long-term IP strategy, for instance, in which the patent portfolio should be attractive to possible investors and licensees, sometimes seems at odds with the short-term company policy. We know exactly how to provide solutions that are workable and effective.

Renowned experts

Our patent attorneys include renowned experts in biotech and life sciences. Some have worked in the life sciences industry, for instance as researcher. All of them are highly dedicated to their profession, and see it as their mission to help companies to build up a sound and balanced IP portfolio that enables these companies to keep up the good work.

Full-service partner

We provide all IP services: drafting and prosecuting patent applications all over the world. We assist you in defending or attacking patents; in infringement suits and in opposition or invalidity proceedings. Other fields of activity are Freedom To Operate analysis, IP audits and Supplementary Protection Certificates for pharmaceuticals and agrochemicals. Particularly for biotech start-ups we commit ourselves to supporting you throughout the different developmental stages of your company. We help you to integrate IP into your operational management and materialize the knowledge assets of your company.

Contact our experts

Jennifer Ebner von Eschenbach

Jennifer Ebner von Eschenbach

  • European Patent Attorney
  • Senior Associate
More experts

News

V.O. strengthens its position in Belgium

Since February 1 Liège is incorporated into our office network. V.O. now has two offices in Belgium – in Leuven and Liège – and eight offices in the Netherlands and Germany. Altogether, more than 60 specialists work in these ten offices, helping all kinds of companies, from tech start-ups to multinationals, maximize the value of […]Continue reading

New on Kluwer Patent Blog: Bayer Intellectual Property GmbH vs. Ceva Santé Animale SA, Nederland

Bayer was not granted an injunction in preliminary proceedings because the Court found that there was a serious chance that Bayer’s patent would be held invalid.Continue reading

New on Kluwer Patent Blog: Recordati Ireland Limited, EPO

A claim defining a compound as having a certain purity would lack novelty over a prior art disclosure describing the same compound only if the prior art disclosed the claimed purity at least implicitly.Continue reading

Events

2nd LIFE-ON-CHIP Conference 2020

Provincie Vlaams-Brabant - Provinciehuis Leuven, Provincieplein, Leuven, Belgium

Micro- and nanotechnology, artificial intelligence, design thinking, robotics, novel manufacturing technologies and big data have made major impacts across all industries, but perhaps their greatest potential impact will be in health and life sciences. Continue reading

MIP International Patent Forum 2020

etc.venues St Paul's, London, UK

As MIP’s flagship event, over 300 IP counsel register every year, connecting senior patent counsel with their peers from across Europe, Asia and the Americas. Join this event to expand your international business network. Continue reading

IP Risk Management Europe 2020

116 Pall Mall, Pall Mall, St. James's, London, UK

IP may be the single most important asset a company possesses. Whether it is physical or digital, customer data or operational information, trade secrets or business strategies, IP is often the main driver of revenue for any organization. Continue reading